Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/openhrt-2021-001633
PubMed Identifier: 34083388
Publication URI: http://europepmc.org/abstract/MED/34083388
Type: Journal Article/Review
Volume: 8
Parent Publication: Open heart
Issue: 1
ISSN: 2053-3624